Psychedelic medicines in major depression: progress and future challenges (2021)
Bouso, Jose Carlos; Ona, Genís; Santos, Rafael Guimarães dos 
; Hallak, Jaime Eduardo Cecilio
Fonte: Major depressive disorder: rethinking and understanding recent discoveries. Unidade: FMRP
Assuntos: DEPRESSÃO, FARMACOTERAPIA, ALUCINOSES, PSIQUIATRIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BOUSO, Jose Carlos et al. Psychedelic medicines in major depression: progress and future challenges. Major depressive disorder: rethinking and understanding recent discoveries. Tradução . Singapore: Springer, 2021. p. 563 . Disponível em: https://doi.org/10.1007/978-981-33-6044-0_26. Acesso em: 21 out. 2025.APA
Bouso, J. C., Ona, G., Santos, R. G. dos, & Hallak, J. E. C. (2021). Psychedelic medicines in major depression: progress and future challenges. In Major depressive disorder: rethinking and understanding recent discoveries (p. 563 ). Singapore: Springer. doi:10.1007/978-981-33-6044-0_26NLM
Bouso JC, Ona G, Santos RG dos, Hallak JEC. Psychedelic medicines in major depression: progress and future challenges [Internet]. In: Major depressive disorder: rethinking and understanding recent discoveries. Singapore: Springer; 2021. p. 563 .[citado 2025 out. 21 ] Available from: https://doi.org/10.1007/978-981-33-6044-0_26Vancouver
Bouso JC, Ona G, Santos RG dos, Hallak JEC. Psychedelic medicines in major depression: progress and future challenges [Internet]. In: Major depressive disorder: rethinking and understanding recent discoveries. Singapore: Springer; 2021. p. 563 .[citado 2025 out. 21 ] Available from: https://doi.org/10.1007/978-981-33-6044-0_26
